Literature DB >> 1671546

Tumor necrosis factor alpha in middle ear cholesteatoma and its effect on keratinocytes in vitro.

S D Yan1, C C Huang.   

Abstract

Tumor necrosis factor alpha (TNF-alpha) was found in human middle ear cholesteatoma tissues by the immunoperoxidase method using rabbit anti human TNF-alpha immunoglobulin G. It appeared to be localized in the epithelium and connective tissue of cholesteatomas studied, particularly on basal and spinous cells, and macrophages. The epithelium of normal external ear canal skin was lightly stained, but the staining was much weaker than that of the cholesteatomas observed. In vitro, recombinant mouse TNF-alpha stimulated proliferation, protein synthesis, and terminal differentiation of basal keratinocytes. These stimulatory effects were blocked by the anti-TNF-alpha immunoglobulin G, which by itself had no effect on basal keratinocytes. These findings suggest that TNF-alpha plays an important role in the development of cholesteatomas seen clinically.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671546     DOI: 10.1177/000348949110000212

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  11 in total

1.  Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas.

Authors:  J Bujía; C Kim; P Ostos; E Kastenbauer; L Hültner
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

2.  Confirmation of mucin in lymphatic vessels of acquired cholesteatoma.

Authors:  Tomoyuki Nagai; Tatsuo Suganuma; Soyuki Ide; Hiroshi Shimoda; Seiji Kato
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-11-22       Impact factor: 2.503

Review 3.  Phenotypic transitions of macrophages orchestrate tissue repair.

Authors:  Margaret L Novak; Timothy J Koh
Journal:  Am J Pathol       Date:  2013-09-30       Impact factor: 4.307

4.  Isolation and characterization of trypsin-like and chymotrypsin-like proteinases from human cholesteatoma.

Authors:  K Hochstrasser; G J Albrecht; W Gebhard; G Rasp; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

5.  Platelet-derived growth factor in middle ear cholesteatoma.

Authors:  O Fujioka; C C Huang
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

6.  Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma.

Authors:  H Shinoda; C C Huang
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

7.  Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity.

Authors:  J Bujía; C Kim; P Ostos; H Sudhoff; E Kastenbauer; L Hültner
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

8.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

Review 9.  Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.

Authors:  Mahmood A Hamed; Seiichi Nakata; Ramadan H Sayed; Hiromi Ueda; Badawy S Badawy; Yoichi Nishimura; Takuro Kojima; Noboru Iwata; Ahmed R Ahmed; Khalid Dahy; Naoki Kondo; Kenji Suzuki
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

10.  Phillygenin Exerts In Vitro and In Vivo Antitumor Effects in Drug-Resistant Human Esophageal Cancer Cells by Inducing Mitochondrial-Mediated Apoptosis, ROS Generation, and Inhibition of the Nuclear Factor kappa B NF-κB Signalling Pathway.

Authors:  Jiantao He; Wei Wei; Qingbo Yang; Yiling Wang
Journal:  Med Sci Monit       Date:  2019-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.